About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2529 blog entries.

Virginia

HB 830, legislation requiring commercial PBMs to utilize pass through pricing models and offer at least one plan that restricts PBM revenue to a set fee, was amended and passed the House unanimouslyThe bill also limits PBMs' ability to charge fees and retroactively reduce pharmacy reimbursement. It is now in the Senate Commerce and Labor Committee and we expect that it will eventually reach Gov. Abigail Spanberger's (D) desk.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-02-27T09:33:45-05:00February 27, 2026|Virginia|

Washington

SSB 5934, the standard of care bill, would expand pharmacists’ practice authority by allowing them to independently prescribe and diagnose within their scope of practice, based on education and experience. The bill passed the Senate earlier this month and is awaiting a hearing in the House Health Care and Wellness Committee. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-27T09:33:11-05:00February 27, 2026|Washington|

West Virginia

HB 5430, legislation that would enact further PBM reforms in the commercial market, Medicaid and under the Public Employee Insurance Agency (PEIA), has passed the House unanimously and is currently in the Senate for further consideration. HB 5430 requires an annual pharmacy dispensing fee study, limits the amounts charged by PBMs and prohibits affiliate pharmacies from contracting with Medicaid and the Public Employee Insurance Agency (PEIA). It also requires the implementation of a pharmacy cost comparison tool on prescriber platforms. We expect the bill to be amended in the Senate before it heads to the floor for a vote.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-02-27T09:32:30-05:00February 27, 2026|West Virginia|

Alaska

On February 16, the House Labor and Commerce Committee held a hearing on HB 195, a bill carried over from last year that would allow pharmacists to provide patient care services within the scope of their education, training and experience. The bill was amended and reported favorably to the House Finance Committee for further consideration.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-20T08:45:09-05:00February 20, 2026|Alaska|

Arkansas

Gov. Sarah Huckaby Sanders (R) reappointed Brian Jolly to the Board of Pharmacy. His term expires June 30, 2031. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-20T08:44:34-05:00February 20, 2026|Arkansas|

California

2026-02-20T08:44:04-05:00February 20, 2026|California|

Indiana

This week, NACDS closely monitored the House Ways and Means Committee’s actions regarding HB 1.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-20T08:43:11-05:00February 20, 2026|Indiana|

Kansas

Two major bills that could change the practice of pharmacy were voted on this week: 

The Senate voted on SB 360, a PBM reform bill that would bring transparency to PBMs, including:  

  • Ending spread pricing: PBMs would no longer be allowed to charge insurers or employers more than they pay pharmacies for the same prescription. 
  • Fair reimbursement: Pharmacies would be paid NADAC + $10.50 (or the state Medicaid rate, whichever is higher). 
  • Lower costs for patients and employers: Savings would go back to health plans, employers and patients instead of being kept by PBMs. 
  • State oversight: PBMs would be regulated by the Kansas Department of Insurance. 

The House voted on HB 2676, allowing for emergency refills for non-controlled medications, and adding pharmacist prescribing in the four categories below:  

  • Conditions not requiring a new diagnosis, such as preventive care and chronic disease management 
  • Conditions that are minor and self-limiting such as hair loss, acne, head lice 
  • Conditions that have a CLIA-waived test to guide next steps, such as respiratory viruses 
  • Patient emergencies, such as epinephrine, beta agonists, glucagon 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-20T08:42:32-05:00February 20, 2026|Kansas|
Go to Top